Home > Publications Database > Acetylation discriminates disease-specific tau deposition. |
Journal Article | DZNE-2023-00955 |
; ; ; ; ; ;
2023
Nature Publishing Group UK
[London]
This record in other databases:
Please use a persistent id in citations: doi:10.1038/s41467-023-41672-1
Abstract: Pathogenic aggregation of the protein tau is a hallmark of Alzheimer's disease and several other tauopathies. Tauopathies are characterized by the deposition of specific tau isoforms as disease-related tau filament structures. The molecular processes that determine isoform-specific deposition of tau are however enigmatic. Here we show that acetylation of tau discriminates its isoform-specific aggregation. We reveal that acetylation strongly attenuates aggregation of four-repeat tau protein, but promotes amyloid formation of three-repeat tau. We further identify acetylation of lysine 298 as a hot spot for isoform-specific tau aggregation. Solid-state NMR spectroscopy demonstrates that amyloid fibrils formed by unmodified and acetylated three-repeat tau differ in structure indicating that site-specific acetylation modulates tau structure. The results implicate acetylation as a critical regulator that guides the selective aggregation of three-repeat tau and the development of tau isoform-specific neurodegenerative diseases.
Keyword(s): Humans (MeSH) ; 14-3-3 Proteins (MeSH) ; Acetylation (MeSH) ; Alzheimer Disease (MeSH) ; tau Proteins (MeSH) ; Tauopathies (MeSH) ; 14-3-3 Proteins ; tau Proteins ; MAPT protein, human
![]() |
The record appears in these collections: |